Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2899 articles about Bristol Myers Squibb Company
-
Life Technologies to Partner With Bristol-Myers Squibb Company for Companion Diagnostics Development
9/17/2012
-
Vical Incorporated Licenses DNA Immunization Technology and Vaxfectin® Adjuvant to Bristol-Myers Squibb Company for Use in Antibody Production
9/13/2012
-
Bristol-Myers Squibb Company to Present at UBS Global Life Sciences Conference
9/13/2012
-
Summit Corporation Inks Breakthrough Seglin Deal With Bristol-Myers Squibb Company
9/11/2012
-
Bristol-Myers Squibb Company to Present at Bank of America Merrill Lynch Global Health Care Conference
9/6/2012
-
Bristol-Myers Squibb Company Recalls Vials of Cancer Drug
9/4/2012
-
Bristol-Myers Squibb Company to Take Part in Morgan Stanley Global Health Care Conference
8/31/2012
-
Bristol-Myers Squibb Company Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss
8/27/2012
-
Alder Biopharmaceuticals Inc. Receives $3.5 Million Milestone Payment From Bristol-Myers Squibb Company for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohn's Disease
8/27/2012
-
Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company
8/24/2012
-
Ever Wonder How Bristol-Myers Squibb Company' Sales Reps Get Motivated?
8/21/2012
-
Bristol-Myers Squibb Company and Pfizer Inc.'s ELIQUIS® (apixaban) Data Analyses to be Presented at European Society of Cardiology Congress 2012
8/20/2012
-
Bristol-Myers Squibb Company Announces Specialty Pharmacy Patient Management Programs for Sprycel® (dasatinib) Patients
8/15/2012
-
Bristol-Myers Squibb Company Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc.
8/8/2012
-
Saladax Biomedical Inc. (SBI) Enters into Master Collaboration Agreement With Bristol-Myers Squibb Company
8/7/2012
-
Bristol-Myers Squibb Company, Others Focus on Fresh Target in Hunt for a Migraine Cure
8/7/2012
-
Bristol-Myers Squibb Company Foundation Awards $1.6 Million in Grants to Help Communities in India Address Type 2 Diabetes
8/7/2012
-
Bristol-Myers Squibb Company Exec Charged With Insider Trading
8/6/2012
-
Bristol-Myers Squibb Company Suspends Hepatitis C Drug Clinical Trial
8/3/2012
-
Natco Pharma Limited in Patent War With Bristol-Myers Squibb Company
8/2/2012